CHRNA1 anticorps (N-Term)

N° du produit ABIN1495052

L’anticorps Lapin Polyclonal anti-CHRNA1 a été validé pour WB, IHC et IHC (p). Il convient pour détecter CHRNA1 dans des échantillons de Humain, Souris et Rat.

Aperçu rapide pour CHRNA1 anticorps (N-Term) (ABIN1495052)

Antigène: CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHRNA1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-CHRNA1 anticorps

Épitope: N-Term

Specificité: Human, mouse, rat. No cross reactivity with other proteins.

Réactivité croisée (Details): No cross reactivity with other proteins.

Purification: Immunoaffinity purified

Immunogène: Synthetic peptide corresponding to a sequence at the N-terminal of acetylcholine receptor alpha1, identical to the related mouse and rat sequence.

Type of Immunogen: Synthetic peptide

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: 5 mg BSA, 0.9 mg sodium chloride, 0.2 mg sodium phosphate, 0.05 mg Thimerosal, 0.05 mg sodium azide

Agent conservateur: Thimerosal (Merthiolate), Sodium azide

Précaution d'utilisation: This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: 4°C
Long term: -20°C.

Détails sur CHRNA1

Antigène: CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))

Autre désignation: CHRNA1

Sujet: Name/Gene ID: CHRNA1
Subfamily: Nicotinic acetylcholine receptor
Family: Ion Channel

Synonyms: CHRNA1, Achr-1, AChR-alpha1, ACHRD, CHNRA, ACHRA, FCCMS, SCCMS, CHRNA, CMS2A, NAChR alpha 1

ID gène: 1134

UniProt: P02708

Pathways: Skeletal Muscle Fiber Development